Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice

Abstract Background New drugs for locally advanced or metastatic breast cancer have led to clinical benefits, aside with increasing costs to healthcare systems. The current financing model for health technology assessment (HTA) privileges real-world data. As part of the ongoing HTA, this study aimed...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Filipa Alves da Costa, Fábio Cardoso Borges, Adriana Ramos, Alexandra Mayer, Claudia Brito, Catarina Ramos, Catarina Bernardo, Mariane Cossito, Cláudia Furtado, Arlindo R. Ferreira, Diogo Martins-Branco, Ana da Costa Miranda, António Lourenço
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2023-06-01
Serie:	Breast Cancer Research
Soggetti:	Palbociclib Effectiveness Safety Cancer registry
Accesso online:	https://doi.org/10.1186/s13058-023-01678-5
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!